Microbiome Therapeutics Market Size by Application, Type, Regional,
Industry Statistics & Forecast 2021 – 2025
Global Microbiome Therapeutics market Size by Type, End User and Application: Global
Opportunity Analysis and Industry Forecast, 2020-2025. The base year considered for the study is
2020, and the forecast has been provided for the period from 2020 to 2025.
The human microbiome is the collection of all the microorganisms living in association with the
human body. These communities consist of a variety of microorganisms including eukaryotes,
archaea, bacteria and viruses. Bacteria in an average human body number ten times more than
human cells, for a total of about 1000 more genes than are present in the human genome. Because
of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass
(thats 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us; in fact they are essential for maintaining health.
For example, they produce some vitamins that we do not have the genes to make, break down our
food to extract nutrients we need to survive, teach our immune systems how to recognize
dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other
An ever-growing number of studies have demonstrated that changes in the composition of our
microbiomes correlate with numerous disease states, raising the possibility that manipulation of
these communities could be used to treat disease.
In the last several years, global market of Microbiome Therapeutics developed rapidly, with an
average growth rate of 98%. In 2020, Global Market Size of Microbiome Therapeutics is nearly 14 M
USD. The Application of Microbiome Therapeutics includes CDI, IBD, Orphan Drug, Immuno-
oncology and Others, and the proportion of R&D Investmen for CDI in 2019 is about 52%, and the
proportion is in Increase trend from 2015 to 2019.
According to this study Microbiome The